Absorb Randomized Controlled Trial – A Clinical Evaluation of Absorb Everolimus Eluting Bioresorbable Vascular Scaffold vs. Xience Drug Eluting Metal Stent in the Treatment of Subjects with de novo Native Coronary Artery Lesions
Compare treatment of lesions (narrowing) in the coronary arteries using bioresorbable stents versus metallic drug-eluting stents. Sponsor: Abbott Vascular.
August 22, 2014
Active/Closed to Enrollment
Thomas Stuver, MD
Tia DeRosa, NP